iRhythm Raises 2026 Revenue Outlook and Expects 2027 Zio MCT FDA Filing

Third-quarter revenue was $221.6 million, up nearly 15% from a year earlier. iRhythm expects Zio AT revenue to decline about 10% in the fourth quarter.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.